Advertisement
Patheon reports "disappointing" third-quarter, net loss $6 million versus year-ago $14-million loss, as revenues plunge 15.7 per cent to $164.4 million due to setback in Puerto Rico operations, slowdown in pharmaceutical development services, other factors.
Advertisement
Advertisement